Acute Leukemia in Remission
10
1
2
3
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
30.0%
3 terminated out of 10 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants